These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 16033844

  • 1. Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.
    Sapra P, Stein R, Pickett J, Qu Z, Govindan SV, Cardillo TM, Hansen HJ, Horak ID, Griffiths GL, Goldenberg DM.
    Clin Cancer Res; 2005 Jul 15; 11(14):5257-64. PubMed ID: 16033844
    [Abstract] [Full Text] [Related]

  • 2. CD74: a new candidate target for the immunotherapy of B-cell neoplasms.
    Stein R, Mattes MJ, Cardillo TM, Hansen HJ, Chang CH, Burton J, Govindan S, Goldenberg DM.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 2):5556s-5563s. PubMed ID: 17875789
    [Abstract] [Full Text] [Related]

  • 3. Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugate.
    Griffiths GL, Mattes MJ, Stein R, Govindan SV, Horak ID, Hansen HJ, Goldenberg DM.
    Clin Cancer Res; 2003 Dec 15; 9(17):6567-71. PubMed ID: 14695162
    [Abstract] [Full Text] [Related]

  • 4. CD74 is expressed by multiple myeloma and is a promising target for therapy.
    Burton JD, Ely S, Reddy PK, Stein R, Gold DV, Cardillo TM, Goldenberg DM.
    Clin Cancer Res; 2004 Oct 01; 10(19):6606-11. PubMed ID: 15475450
    [Abstract] [Full Text] [Related]

  • 5. Therapy of small subcutaneous B-lymphoma xenografts with antibodies conjugated to radionuclides emitting low-energy electrons.
    Michel RB, Rosario AV, Andrews PM, Goldenberg DM, Mattes MJ.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):777-86. PubMed ID: 15701868
    [Abstract] [Full Text] [Related]

  • 6. Therapy of disseminated B-cell lymphoma xenografts in severe combined immunodeficient mice with an anti-CD74 antibody conjugated with (111)indium, (67)gallium, or (90)yttrium.
    Ochakovskaya R, Osorio L, Goldenberg DM, Mattes MJ.
    Clin Cancer Res; 2001 Jun 15; 7(6):1505-10. PubMed ID: 11410483
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
    Lopes de Menezes DE, Pilarski LM, Allen TM.
    Cancer Res; 1998 Aug 01; 58(15):3320-30. PubMed ID: 9699662
    [Abstract] [Full Text] [Related]

  • 8. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.
    Bellamy WT, Odeleye A, Huizenga E, Dalton WS, Weinstein RS, Grogan TM.
    Clin Cancer Res; 1995 Dec 01; 1(12):1563-70. PubMed ID: 9815957
    [Abstract] [Full Text] [Related]

  • 9. [Monoclonal antibody against brain derived neurotrophic factor inhibits myeloma growth and angiogenesis in the xenograft NOD/SCID animal model].
    Wang YD, Hu Y, Zhang L, Huang J, Sun CY.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct 01; 28(10):659-63. PubMed ID: 18399169
    [Abstract] [Full Text] [Related]

  • 10. The use of daunomycin-antibody immunoconjugates in managing soft tissue sarcomas: nude mouse xenograft model.
    Stastny JJ, Das Gupta TK.
    Cancer Res; 1993 Dec 01; 53(23):5740-4. PubMed ID: 8242630
    [Abstract] [Full Text] [Related]

  • 11. Efficacy, biodistribution, and pharmacokinetics of CD22-targeted pegylated liposomal doxorubicin in a B-cell non-Hodgkin's lymphoma xenograft mouse model.
    Tuscano JM, Martin SM, Ma Y, Zamboni W, O'Donnell RT.
    Clin Cancer Res; 2010 May 15; 16(10):2760-8. PubMed ID: 20460479
    [Abstract] [Full Text] [Related]

  • 12. The Fc portion of UV3, an anti-CD54 monoclonal antibody, is critical for its antitumor activity in SCID mice with human multiple myeloma or lymphoma cell lines.
    Coleman EJ, Brooks KJ, Smallshaw JE, Vitetta ES.
    J Immunother; 2006 May 15; 29(5):489-98. PubMed ID: 16971805
    [Abstract] [Full Text] [Related]

  • 13. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
    Sharkey RM, Karacay H, Johnson CR, Litwin S, Rossi EA, McBride WJ, Chang CH, Goldenberg DM.
    J Nucl Med; 2009 Mar 15; 50(3):444-53. PubMed ID: 19223402
    [Abstract] [Full Text] [Related]

  • 14. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M, Egilmez NK, Yokota SJ, Chen FA, Harding J, Huang SK, Bankert RB.
    Cancer Res; 2000 Dec 15; 60(24):6942-9. PubMed ID: 11156394
    [Abstract] [Full Text] [Related]

  • 15. Significance of antigen, drug, and tumor cell targets in the preclinical evaluation of doxorubicin, daunorubicin, methotrexate, and mitomycin-C monoclonal antibody immunoconjugates.
    Dillman RO, Johnson DE, Ogden J, Beidler D.
    Mol Biother; 1989 Dec 15; 1(5):250-5. PubMed ID: 2515870
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells.
    Tassone P, Gozzini A, Goldmacher V, Shammas MA, Whiteman KR, Carrasco DR, Li C, Allam CK, Venuta S, Anderson KC, Munshi NC.
    Cancer Res; 2004 Jul 01; 64(13):4629-36. PubMed ID: 15231675
    [Abstract] [Full Text] [Related]

  • 17. In vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugate.
    Sanderson RJ, Hering MA, James SF, Sun MM, Doronina SO, Siadak AW, Senter PD, Wahl AF.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):843-52. PubMed ID: 15701875
    [Abstract] [Full Text] [Related]

  • 18. Effective therapy of human lymphoma xenografts with a novel recombinant ribonuclease/anti-CD74 humanized IgG4 antibody immunotoxin.
    Chang CH, Sapra P, Vanama SS, Hansen HJ, Horak ID, Goldenberg DM.
    Blood; 2005 Dec 15; 106(13):4308-14. PubMed ID: 16109781
    [Abstract] [Full Text] [Related]

  • 19. Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies.
    Stein R, Qu Z, Cardillo TM, Chen S, Rosario A, Horak ID, Hansen HJ, Goldenberg DM.
    Blood; 2004 Dec 01; 104(12):3705-11. PubMed ID: 15297317
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.